Edges in Network
| Network | GSE12093_top8000 - GSE12093 - SiGN-BN NNSR |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | SLC1A7 |
| Upstream (Parents) |
|---|
| (<<) LOC222070 → SLC1A7 |
| Downstream (Children) |
|---|
| SLC1A7 → TCP10 (>>) |
| SLC1A7 → NIPSNAP3B (>>) |
| SLC1A7 → KIR2DL2 (>>) |
| SLC1A7 → RASAL1 (>>) |
| SLC1A7 → MYH15 (>>) |
| SLC1A7 → COBLL1 (>>) |
| SLC1A7 → FBXO4 (>>) |
| SLC1A7 → ABP1 (>>) |
| SLC1A7 → PCSK2 (>>) |
| SLC1A7 → ART3 (>>) |
| SLC1A7 → ZNF536 (>>) |
| SLC1A7 → FPR2 (>>) |
| SLC1A7 → HTR2A (>>) |
| SLC1A7 → KIR3DX1 (>>) |
| SLC1A7 → MYF6 (>>) |
| SLC1A7 → HTR3B (>>) |
| SLC1A7 → BTN2A3 (>>) |
| SLC1A7 → CFLAR (>>) |
| SLC1A7 → BFSP2 (>>) |
| SLC1A7 → LMO3 (>>) |
| SLC1A7 → PRSS12 (>>) |
| SLC1A7 → CYP4A22 (>>) |
| SLC1A7 → TKTL1 (>>) |
| SLC1A7 → HAP1 (>>) |
| SLC1A7 → CNKSR2 (>>) |
| SLC1A7 → RPL14 (>>) |
| SLC1A7 → NCRNA00185 (>>) |
| SLC1A7 → PIGR (>>) |
| SLC1A7 → KIF5A (>>) |
| SLC1A7 → LEFTY1 (>>) |
| SLC1A7 → IL18BP (>>) |
| SLC1A7 → PSG9 (>>) |
